Nurix Therapeutics (NASDAQ:NRIX) Coverage Initiated by Analysts at Truist Financial
Truist Financial assumed coverage on shares of Nurix Therapeutics (NASDAQ:NRIX – Free Report) in a research report sent to investors on Wednesday, MarketBeat reports. The firm issued a buy rating and a $36.00 price objective on the stock. A number of other brokerages have also commented on NRIX. Stephens initiated coverage on Nurix Therapeutics in […]
More Stories
Venture Life Group (LON:VLG) Stock Price Crosses Below Fifty Day Moving Average – Should You Sell?
Venture Life Group plc (LON:VLG – Get Free Report)’s stock price crossed below its 50-day moving average during trading on...
Geoffrey Richards Sells 4,607 Shares of Travel + Leisure Co. (NYSE:TNL) Stock
Travel + Leisure Co. (NYSE:TNL – Get Free Report) insider Geoffrey Richards sold 4,607 shares of the firm’s stock in...
JPMorgan Chase & Co. Issues Positive Forecast for Credicorp (NYSE:BAP) Stock Price
Credicorp (NYSE:BAP – Free Report) had its price target boosted by JPMorgan Chase & Co. from $200.00 to $219.00 in...
Erdene Resource Development (TSE:ERD) Shares Cross Below 50-Day Moving Average – Here’s What Happened
Erdene Resource Development Co. (TSE:ERD – Get Free Report)’s stock price crossed below its 50 day moving average during trading...
Farmland Partners Inc. (NYSE:FPI) Shares Sold by Ashton Thomas Private Wealth LLC
Ashton Thomas Private Wealth LLC trimmed its stake in shares of Farmland Partners Inc. (NYSE:FPI – Free Report) by 64.1%...
Redde Northgate (LON:REDD) Stock Crosses Above Fifty Day Moving Average – Time to Sell?
Redde Northgate plc (LON:REDD – Get Free Report)’s share price crossed above its 50 day moving average during trading on...